Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Meek, P. Mills, H. Gray, J. Duncan, R. Russell, J. Mckillop (1984)
A comparison of computed tomography, ultrasound and scintigraphy in the diagnosis of alcoholic liver disease.The British journal of radiology, 57 673
Robert Myers, A. Pollett, R. Kirsch, G. Pomier‐Layrargues, M. Beaton, M. Levstik, A. Duarte-Rojo, David Wong, P. Crotty, M. Elkashab (2012)
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastographyLiver International, 32
Psychol Methods, 9
U. Mathiesen, L. Franzén, H. Aselius, M. Resjö, L. Jacobsson, U. Foberg, A. Frydén, G. Bodemar (2002)
Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 34 7
(2006)
Nonalcoholic fatty liver disease: from steatosis to cirrhosisHepatology, 43
S. Strauss, E. Gavish, P. Gottlieb, L. Katsnelson (2007)
Interobserver and intraobserver variability in the sonographic assessment of fatty liver.AJR. American journal of roentgenology, 189 6
L. Adams, S. Sanderson, K. Lindor, P. Angulo (2005)
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.Journal of hepatology, 42 1
K. Taylor, F. Gorelick, A. Rosenfield, C. Riely (1981)
Ultrasonography of alcoholic liver disease with histological correlation.Radiology, 141 1
S. Saadeh, Z. Younossi, E. Remer, T. Gramlich, J. Ong, M. Hurley, K. Mullen, J. Cooper, M. Sheridan (2002)
The utility of radiological imaging in nonalcoholic fatty liver disease.Gastroenterology, 123 3
(2007)
Comparison of CT methods for determining the fat content of the liverAm J Roentgenol, 188
C. Caussy, Mosab Alquiraish, P. Nguyen, C. Hernandez, Sandra Cepin, Lynda Fortney, V. Ajmera, R. Bettencourt, Summer Collier, J. Hooker, Ethan Sy, E. Rizo, L. Richards, C. Sirlin, R. Loomba (2018)
Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosisHepatology, 67
N. Tamaki, Y. Koizumi, M. Hirooka, N. Yada, Hitomi Takada, O. Nakashima, M. Kudo, Y. Hiasa, N. Izumi (2018)
Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement methodHepatology Research, 48
A. Tang, Ajinkya Desai, G. Hamilton, T. Wolfson, A. Gamst, Jessica Lam, Lisa Clark, J. Hooker, Tanya Chavez, Brandon Ang, M. Middleton, M. Peterson, R. Loomba, C. Sirlin (2015)
Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease.Radiology, 274 2
D. Joy, V. Thava, B. Scott (2003)
Diagnosis of fatty liver disease: is biopsy necessary?European Journal of Gastroenterology & Hepatology, 15
M. Sasso, I. Tengher-Barna, M. Ziol, V. Miette, C. Fournier, L. Sandrin, R. Poupon, A. Cardoso, P. Marcellin, C. Douvin, V. Ledinghen, J. Trinchet, M. Beaugrand (2012)
Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis CJournal of Viral Hepatitis, 19
T. Tada, T. Kumada, H. Toyoda, Natsuko Kobayashi, Y. Sone, Takuma Oguri, N. Kamiyama (2019)
Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction.AJR. American journal of roentgenology, 212 2
V. Lédinghen, J. Vergniol, M. Capdepont, F. Chermak, J. Hiriart, C. Cassinotto, Wassil Merrouche, J. Foucher, Le Brigitte (2014)
Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.Journal of hepatology, 60 5
Valéria Borges, A. Diniz, H. Cotrim, H. Rocha, Nestor Andrade (2013)
Sonographic hepatorenal ratio: A noninvasive method to diagnose nonalcoholic steatosisJournal of Clinical Ultrasound, 41
J. Bartlett, C. Frost (2008)
Reliability, repeatability and reproducibility: analysis of measurement errors in continuous variablesUltrasound in Obstetrics and Gynecology, 31
I. Gatos, P. Drazinos, S. Yarmenitis, I. Theotokas, P. Zoumpoulis (2020)
Comparison of Sound Touch Elastography, Shear Wave Elastography and Vibration-Controlled Transient Elastography in Chronic Liver Disease Assessment using Liver Biopsy as the "Reference Standard".Ultrasound in medicine & biology
P. Mishra, Z. Younossi (2007)
Abdominal Ultrasound for Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD)The American Journal of Gastroenterology, 102
K. McGraw, S. Wong (1996)
Forming inferences about some intraclass correlation coefficients.Psychological Methods, 1
M. Sasso, M. Beaugrand, V. Lédinghen, C. Douvin, P. Marcellin, R. Poupon, L. Sandrin, V. Miette (2010)
Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.Ultrasound in medicine & biology, 36 11
Yueyan Hu, Ning-Ling Dong, Qiu Qu, Xu Zhao, Hongjuan Yang (2018)
The correlation between controlled attenuation parameter and metabolic syndrome and its components in middle-aged and elderly nonalcoholic fatty liver disease patientsMedicine, 97
Transplantation, 97
Eur J Gastroenterol Hepatol, 15
K. Pu, Yuping Wang, Su-Yang Bai, Hui Wei, Yongning Zhou, Jian-Gao Fan, L. Qiao (2019)
Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysisBMC Gastroenterology, 19
F. Angelico, M. Ben, R. Conti, S. Francioso, K. Feole, S. Fiorello, M. Cavallo, B. Zalunardo, F. Lirussi, C. Alessandri, F. Violi (2005)
Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease.The Journal of clinical endocrinology and metabolism, 90 3
Charlie Park, P. Nguyen, C. Hernandez, R. Bettencourt, Kim Ramirez, Lynda Fortney, J. Hooker, Ethan Sy, Michael Savides, Mosab Alquiraish, M. Valasek, E. Rizo, L. Richards, D. Brenner, C. Sirlin, R. Loomba (2017)
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.Gastroenterology, 152 3
Z. Younossi (2019)
Non-alcoholic fatty liver disease - A global public health perspective.Journal of hepatology, 70 3
E. Carey, W. Carey (2010)
Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete?Cleveland Clinic Journal of Medicine, 77
V. Ratziu, F. Charlotte, A. Heurtier, S. Gombert, P. Giral, E. Bruckert, A. Grímaldi, F. Capron, T. Poynard (2005)
Sampling variability of liver biopsy in nonalcoholic fatty liver disease.Gastroenterology, 128 7
V. Ledinghen, J. Vergniol, J. Foucher, Wassil Merrouche, B. Bail (2012)
Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastographyLiver International, 32
Richard Marshall, M. Eissa, E. Bluth, P. Gulotta, N. Davis (2012)
Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis.AJR. American journal of roentgenology, 199 5
G. Ferraioli, L. Maiocchi, M. Raciti, C. Tinelli, A. Silvestri, M. Nichetti, P. Cata, M. Rondanelli, L. Chiovato, F. Calliada, C. Fìlice (2019)
Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold StandardClinical and Translational Gastroenterology, 10
Hepatology, 43
M. Sasso, V. Miette, L. Sandrin, M. Beaugrand (2012)
The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan.Clinics and research in hepatology and gastroenterology, 36 1
R. Hernaez, M. Lazo, S. Bonekamp, I. Kamel, F. Brancati, E. Guallar, J. Clark (2011)
Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysisHepatology, 54
G. Farrell, C. Larter (2006)
LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Incidence of complications from percutaneous biopsy in chronic liver disease: a systematic review and meta-analysis [published online June 15, 2021]
Dig Dis Sci
T. Karlas, D. Petroff, M. Sasso, Jian-Gao Fan, Y. Mi, V. Lédinghen, M. Kumar, M. Lupsor-Platon, K. Han, A. Cardoso, G. Ferraioli, W. Chan, V. Wong, R. Myers, K. Chayama, M. Friedrich-Rust, M. Beaugrand, F. Shen, J. Hiriart, S. Sarin, R. Badea, K. Jung, P. Marcellin, C. Fìlice, S. Mahadeva, G. Wong, P. Crotty, Keiichi Masaki, J. Bojunga, P. Bedossa, V. Keim, J. Wiegand (2017)
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.Journal of hepatology, 66 5
Z. Younossi, M. Stepanova, Mariam Afendy, Yun Fang, Youssef Younossi, Hesham Mir, Manirath Srishord (2011)
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 9 6
Ke-Qing Shi, Jun Tang, Xuelian Zhu, Li Ying, De-wei Li, Jian Gao, Y. Fang, Guiling Li, Yi-Jiang Song, Zhu-jun Deng, Jianmin Wu, Kai-Fu Tang (2014)
Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: A meta‐analysis of diagnostic accuracyJournal of Gastroenterology and Hepatology, 29
Z. Goodman (2007)
Grading and staging systems for inflammation and fibrosis in chronic liver diseases.Journal of hepatology, 47 4
P. Charatcharoenwitthaya, K. Lindor (2007)
Role of radiologic modalities in the management of non-alcoholic steatohepatitis.Clinics in liver disease, 11 1
H. Thomaides-Brears, N. Alkhouri, D. Allende, M. Harisinghani, M. Noureddin, N. Reau, M. French, C. Pantoja, S. Mouchti, D. Cryer (2021)
Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-AnalysisDigestive Diseases and Sciences, 67
M. Lupsor-Platon, H. Stefanescu, D. Muresan, M. Florea, Mária Szász, A. Maniu, R. Badea (2014)
Noninvasive assessment of liver steatosis using ultrasound methods.Medical ultrasonography, 16 3
M. Burgio, M. Imbault, M. Ronot, A. Faccinetto, B. Beers, P. Rautou, L. Castéra, J. Gennisson, M. Tanter, V. Vilgrain (2018)
Ultrasonic Adaptive Sound Speed Estimation for the Diagnosis and Quantification of Hepatic Steatosis: A Pilot StudyUltraschall in der Medizin - European Journal of Ultrasound, 40
Jong Chung, Hyung Ahn, Sang Kim, Y. Lee, Y. Kim, S. Jeong, J. Jang, Sae-Hwan Lee, Hong Kim, B. Kim (2013)
The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosisClinical and molecular hepatology, 19
J. Neuberger, J. Patel, H. Caldwell, S. Davies, Vanessa Hebditch, C. Hollywood, S. Hubscher, S. Karkhanis, W. Lester, N. Roslund, R. West, J. Wyatt, M. Heydtmann (2020)
Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of PathologyGut, 69
Charlie Park, P. Nguyen, C. Hernandez, R. Bettencourt, Kim Ramirez, Lynda Fortney, J. Hooker, Ethan Sy, Mosab Alquiraish, M. Valasek, E. Rizo, L. Richards, D. Brenner, C. Sirlin, R. Loomba (2017)
Magnetic resonance elastography vs. transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver diseaseJournal of Hepatology, 66
Q. Zeng, Zhenya Song, Yi Zhao, Jianjun Wu, Liu-hong Wang, H. Ye, Yingwei Wang, Ting Wu, Sishu Yuan, Haojie Yuan (2019)
Controlled attenuation parameter by vibration‐controlled transient elastography for steatosis assessment in members of the public undergoing regular health checkups with reference to magnetic resonance imaging‐based proton density fat fractionHepatology Research, 50
Med Ultrason, 16
Brad Starley, Christopher Calcagno, S. Harrison (2010)
Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connectionHepatology, 51
Kento Imajo, Takaomi Kessoku, Y. Honda, Wataru Tomeno, Y. Ogawa, H. Mawatari, K. Fujita, M. Yoneda, M. Taguri, H. Hyogo, Y. Sumida, M. Ono, Y. Eguchi, Tomio Inoue, T. Yamanaka, K. Wada, S. Saito, A. Nakajima (2016)
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.Gastroenterology, 150 3
M. Webb, H. Yeshua, S. Zelber-Sagi, E. Santo, E. Brazowski, Z. Halpern, R. Oren (2009)
Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis.AJR. American journal of roentgenology, 192 4
N. Schwenzer, F. Springer, C. Schraml, N. Stefan, J. Machann, F. Schick (2009)
Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.Journal of hepatology, 51 3
R. Vuppalanchi, A. Unalp, M. Natta, O. Cummings, K. Sandrasegaran, T. Hameed, J. Tonascia, N. Chalasani (2009)
Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 7 4
Chao-Long Chen, Yu-Fan Cheng, Chun-Yen Yu, H. Ou, L. Tsang, Tung‐liang Huang, Tai‐yi Chen, A. Concejero, Chi-Chih Wang, Shih‐Ho Wang, Tsan‐Shiun Lin, Yueh-Wei Liu, Chin‐Hsiang Yang, C. Yong, K. Chiu, B. Jawan, H. Eng, See-Ching Chan, W. Sharr, C. Lo, S. Tamura, Y. Sugawara, N. Kokudo, Kwang-Wonng Lee, N. Yi, K. Suh, D. Moon, Sung‐Gyu Lee, C. Ahn, S. Huang, Ki‐Hun Kim, T. Ha, G. Song, D. Jung, G. Park, J. Namkoong, Hyung‐Woo Park, Yohan Park, Cheon-Soo Park, Kyw-Bo Sung, G. Ko, D. Gwon, Toskimi Kaido, K. Ogawa, Y. Fujimoto, Takashi Ito, Koji Toniyama, A. Mori, Y. Ogura, S. Uemoto, A. Yap, Yu-Hung Lin, Chun-yi Liu, Y. Chiang, Chih-Chi Lin, M. Shin, J. Joh, Catherine Kabiling, Tsung‐Hui Hu, Sung-Hwa Kang, Bo-Hyun Jung, Y. Choi (2014)
Living donor liver transplantation: the Asian perspective.Transplantation, 97 Suppl 8
P. Limanond, S. Raman, C. Lassman, J. Sayre, R. Ghobrial, R. Busuttil, S. Saab, D. Lu (2004)
Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.Radiology, 230 1
B. Guiu, R. Loffroy, P. Hillon, J. Petit (2009)
Magnetic resonance imaging and spectroscopy for quantification of hepatic steatosis: urgent need for standardization!Journal of hepatology, 51 6
Y. Kodama, C. Ng, Tsung-Teh Wu, G. Ayers, S. Curley, E. Abdalla, J. Vauthey, C. Charnsangavej (2007)
Comparison of CT methods for determining the fat content of the liver.AJR. American journal of roentgenology, 188 5
Yudai Fujiwara, Hidekatsu Kuroda, Tamami Abe, K. Ishida, Takuma Oguri, Sachiyo Noguchi, T. Sugai, N. Kamiyama, Y. Takikawa (2018)
The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease.Ultrasound in medicine & biology, 44 11
I. Sporea, S. Bota, O. Grădinaru-Taşcău, R. Șirli, A. Popescu, A. Jurchiș (2014)
Which are the cut-off values of 2D-Shear Wave Elastography (2D-SWE) liver stiffness measurements predicting different stages of liver fibrosis, considering Transient Elastography (TE) as the reference method?European journal of radiology, 83 3
Objectives Nonalcoholic fatty liver disease (NAFLD) is the most widespread chronic liver disease type in the Western countries. Ultrasound (US) is used for NAFLD and hepatic steatosis (HS) grading. The most popular US method for NAFLD assessment is the hepatorenal index (HRI), but because of its limitations, other noninvasive methods have been developed. The Resona 7 US system has recently incorporated an US attenuation–related quantitative feature, liver ultrasound attenuation (LiSA), for HS estimation. The purpose of this study is to compare LiSA’s and HRI’s performance on NAFLD assessment. Methods A total of 159 NAFLD patients having a magnetic resonance imaging–proton density fat fraction (MRI-PDFF) examination were examined by 2 radiologists, who performed LiSA and HRI measurements in the liver. Correlation of LiSA's and HRI's measurements with MRI-PDFF values was calculated through Pearson correlation coefficient (PCC). To further investigate the performance of LiSA and HRI, optimum cutoffs, provided by the literature, were used to correspond HS grades to MRI-PDFF results. Moreover, a receiver operating characteristic (ROC) analysis on LiSA measurements and steatosis grades was performed. Results Magnetic resonance imaging–PDFF was better correlated with LiSA (PCC = 0.80) than HRI (PCC = 0.67). Receiver operating characteristic analysis showed better performance range for LiSA (77.8%–91.8%) than for HRI (72.8%–85.4%) on all HS grades for all studies used for corresponding MRI-PDFF values to HS grades. Conclusions The results indicate that LiSA is more accurate than HRI in HS differentiation and can lead to more accurate grading of HS on NAFLD patients.
Ultrasound Quarterly – Wolters Kluwer Health
Published: Mar 30, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.